Business Context and Reporting Period
Keros Therapeutics, Inc. (KROS) filed a Current Report on Form 8-K dated September 7, 2021. The filing discloses the entry into a material definitive agreement for a new principal executive office and laboratory space in Lexington, Massachusetts.
Key Financial Metrics and Obligations
This filing does not report revenue, profit, cash flow, or operating margins. It details specific financial obligations related to a new lease agreement:
- Lease Term: 8 years and 4 months, with an option to extend for an additional 5 years.
- Base Rent: Fixed at $202,084.66 per month, increasing by approximately 3% annually.
- Rent Commencement: Four months after the Commencement Date (expected on or prior to October 21, 2022).
- Tenant Improvements: Landlord to provide up to approximately $6.8 million in improvements.
- Security Deposit: A letter of credit of approximately $1.2 million, potentially reducible to $0.8 million after four years.
Material Changes
The primary material change is the execution of a lease for approximately 35,662 square feet of office and laboratory space. This represents a significant expansion of the company's physical footprint and creates a new long-term fixed cost obligation starting in 2023.
Outlook, Risks, and Contingencies
Management Commentary: The lease is intended to serve as the Company's new principal executive office. The Landlord is responsible for substantial improvements prior to occupancy.
Risks and Contingencies:
- Termination Rights: The Company may terminate the lease if landlord work does not commence by July 1, 2022, or if the premises are not ready for occupancy within a specified timeframe after October 21, 2022.
- Default: The Landlord retains the right to terminate upon customary events of default.
- Off-Balance Sheet Obligation: The filing explicitly notes the creation of a direct financial obligation under Item 2.03.
Investor Verification Checklist
- Verify the actual Commencement Date and Rent Commencement Date in future filings to confirm the start of cash outflows.
- Monitor the status of the $6.8 million in tenant improvements to ensure they meet the Company's operational needs.
- Review the upcoming Form 10-Q for the period ending September 30, 2021, for the full text of the Lease agreement.
- Assess the impact of the $202,084.66 monthly rent obligation on the Company's future cash burn rate and liquidity.